MoneyWorks4Me

Sigachi Industries - Quaterly Results

13 May 2022 Evaluate
The sales figure stood at Rs. 708.70 millions for the March 2022 quarter. The mentioned figure indicates a growth of about 44.46% as compared to Rs. 490.58 millions during the year-ago period.The Company has registered profit of Rs. 104.26  millions for the quarter ended March 2022, a growth of 20.21%  over Rs. 86.73 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 149.38 millions from the corresponding previous quarter of 114.73 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 708.70 490.58 44.46 2494.05 1879.42 32.70 2494.05 1879.42 32.70
Other Income 17.29 6.76 155.77 26.30 32.55 -19.20 26.30 32.55 -19.20
PBIDT 149.38 114.73 30.20 530.26 405.89 30.64 530.26 405.89 30.64
Interest 4.75 2.05 131.71 11.55 11.59 -0.35 11.55 11.59 -0.35
PBDT 144.63 112.68 28.35 518.71 394.30 31.55 518.71 394.30 31.55
Depreciation 8.00 6.30 26.98 29.05 23.11 25.70 29.05 23.11 25.70
PBT 136.63 106.38 28.44 489.66 371.19 31.92 489.66 371.19 31.92
TAX 32.37 19.65 64.73 109.37 80.60 35.69 109.37 80.60 35.69
Deferred Tax 4.75 1.52 212.50 10.53 14.94 -29.52 10.53 14.94 -29.52
PAT 104.26 86.73 20.21 380.29 290.59 30.87 380.29 290.59 30.87
Equity 307.43 76.83 300.14 307.43 76.83 300.14 307.43 76.83 300.14
PBIDTM(%) 21.08 23.39 -9.87 21.26 21.60 -1.55 21.26 21.60 -1.55
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..